The role of the dopamine transporter in dopamine-induced DNA damage

Brain Pathology

Volumn 21, Issue 3, 2011, Pages 237-248

  Fazeli, Gholamreza ^a   Oli, Rajaraman Gnana ^a   Schupp, Nicole ^a   Stopper, Helga ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

dopamine; dopamine transporter; dopamine type 2 receptor; genotoxicity; micronucleus

Indexed keywords

8 HYDROXYGUANINE; AMINE OXIDASE (FLAVIN CONTAINING); DNA; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GENOMIC DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROGEN PEROXIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; QUINPIROLE; SULPIRIDE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN; CHROMOSOME DAMAGE; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; DOPAMINE UPTAKE; ENZYME INHIBITION; GENE EXPRESSION; GENOTOXICITY; HUMAN; IMMUNOCYTOCHEMISTRY; MASS SPECTROMETRY; MICRONUCLEUS TEST; NONHUMAN; OXIDATION; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DEOXYGUANOSINE; DNA DAMAGE; DOGS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOHISTOCHEMISTRY; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MONOAMINE OXIDASE; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION;

EID: 79954584240     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2010.00440.x     Document Type: Article

References (55)

1. Benzie IF, Strain JJ, (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239: 70-76.
2. Betteridge DJ, (2000) What is oxidative stress? Metabolism 49: 3-8. (Pubitemid 30091785)
3. Bisaglia M, Mammi S, Bubacco L, (2007) Kinetic and structural analysis of the early oxidation products of dopamine-Analysis of the interactions with alpha-synuclein. J Biol Chem 282: 15597-15605. (Pubitemid 47093273)
4. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ, (1998) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44: 169-178. (Pubitemid 28378299)
5. Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, et al, (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71: 1222-1232. (Pubitemid 46661542)
6. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, et al, (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28: 625-631. (Pubitemid 46523357)
7. Brajter-Toth A, Chambers JQ, (2002) Electroanalytical Methods for Biological Materials. Marcel Dekker: New York.
8. Brink A, Lutz U, Volkel W, Lutz WK, (2006) Simultaneous determination of O6-methyl-2′-deoxyguanosine, 8-oxo-7,8-dihydro-2′-deoxyguanosine, and 1,N6-etheno-2′-deoxyadenosine in DNA using on-line sample preparation by HPLC column switching coupled to ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 830: 255-261. (Pubitemid 43075460)
9. Cadet JL, Brannock C, (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32: 117-131. (Pubitemid 28105298)
10. Cai G, Zhen X, Uryu K, Friedman E, (2000) Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J Neurosci 20: 1849-1857. (Pubitemid 30220382)
11. Carvelli L, Moron JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, et al, (2002) PI 3-kinase regulation of dopamine uptake. J Neurochem 81: 859-869. (Pubitemid 34809314)
12. Chao MR, Yen CC, Hu CW, (2008) Prevention of artifactual oxidation in determination of cellular 8-oxo-7,8-dihydro-2′-deoxyguanosine by isotope-dilution LC-MS/MS with automated solid-phase extraction. Free Radic Biol Med 44: 464-473.
13. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA, (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J Biol Chem 267: 166-172.
14. Cornetta T, Palma S, Aprile I, Padua L, Tonali P, Testa A, Cozzi R, (2009) Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease. Cell Biol Toxicol 25: 321-330.
15. Daniels GM, Amara SG, (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274: 35794-35801. (Pubitemid 129512883)
16. Doggrell SA, (2002) The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert Opin Investig Drugs 11: 631-644. (Pubitemid 34520614)
17. Fenech M, (2000) The in vitro micronucleus technique. Mutat Res 455: 81-95.
18. Fleckenstein AE, Pogun S, Carroll FI, Kuhar MJ, (1996) Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]. J Pharmacol Exp Ther 279: 200-206.
19. Floyd RA, (1990) The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11: 1447-1450. (Pubitemid 20281454)
20. Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG, (2007) Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids 32: 213-224. (Pubitemid 46198745)
21. Gerdin MJ, Eiden LE, (2007) Regulation of PC12 cell differentiation by cAMP signaling to ERK independent of PKA: do all the connections add up? Sci STKE 2007: pe15.
22. Giros B, Caron MG, (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14: 43-49. (Pubitemid 23049339)
23. Gu HH, Ahn J, Caplan MJ, Blakely RD, Levey AI, Rudnick G, (1996) Cell-specific sorting of biogenic amine transporters expressed in epithelial cells. J Biol Chem 271: 18100-18106. (Pubitemid 26250798)
24. Gu Q, Shi X, Yin P, Gao P, Lu X, Xu G, (2008) Analysis of catecholamines and their metabolites in adrenal gland by liquid chromatography tandem mass spectrometry. Anal Chim Acta 609: 192-200.
25. Guyton KZ, Kensler TW, (1993) Oxidative mechanisms in carcinogenesis. Brit Med Bull 49: 523-544. (Pubitemid 23243827)
26. Hermida-Ameijeiras A, Mendez-Alvarez E, Sanchez-Iglesias S, Sanmartin-Suarez C, Soto-Otero R, (2004) Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Int 45: 103-116. (Pubitemid 38479570)
27. Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI, (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388: 211-227. (Pubitemid 27471497)
28. Hyman SE, (1996) Addiction to cocaine and amphetamine. Neuron 16: 901-904. (Pubitemid 26171195)
29. Jeon S, Park JK, Bae CD, Park J, (2010) NGF-induced moesin phosphorylation is mediated by the PI3K, Rac1 and Akt and required for neurite formation in PC12 cells. Neurochem Int 56: 810-818.
30. Johnson C, Sanders K, Fan H, (2010) Jaagsiekte sheep retrovirus transformation in madin-darby canine kidney epithelial cell 3-D culture. J Virol 84: 5379-5390.
31. Kamata Y, Shiraga H, Tai A, Kawamoto Y, Gohda E, (2007) Induction of neurite outgrowth in PC12 cells by the medium-chain fatty acid octanoic acid. Neuroscience 146: 1073-1081. (Pubitemid 46694153)
32. Kawano T, Pinontoan R, Uozumi N, Morimitsu Y, Miyake C, Asada K, Muto S, (2000) Phenylethylamine-induced generation of reactive oxygen species and ascorbate free radicals in tobacco suspension culture: mechanism for oxidative burst mediating Ca2+ influx. Plant Cell Physiol 41: 1259-1266. (Pubitemid 32003663)
33. Kelemen BR, Hsiao K, Goueli SA, (2002) Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides. J Biol Chem 277: 8741-8748. (Pubitemid 34968342)
34. Kierbel A, Gassama-Diagne A, Mostov K, Engel JN, (2005) The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell 16: 2577-2585. (Pubitemid 40632236)
35. Klaunig JE, Kamendulis LM, (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol 44: 239-267. (Pubitemid 38263841)
36. Li MW, Martin RS, (2008) Microchip-based integration of cell immobilization, electrophoresis, post-column derivatization, and fluorescence detection for monitoring the release of dopamine from PC 12 cells. The Analyst 133: 1358-1366.
37. Lin Z, Zhang PW, Zhu X, Melgari JM, Huff R, Spieldoch RL, Uhl GR, (2003) Phosphatidylinositol 3-kinase, protein kinase C, and MEK1/2 kinase regulation of dopamine transporters (DAT) require N-terminal DAT phosphoacceptor sites. J Biol Chem 278: 20162-20170. (Pubitemid 36799211)
38. Loder MK, Melikian HE, (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278: 22168-22174. (Pubitemid 36792628)
39. Loft S, Poulsen HE, (1996) Cancer risk and oxidative DNA damage in man. J Mol Med 74: 297-312. (Pubitemid 26195901)
40. Mayfield RD, Zahniser NR, (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol 59: 113-121. (Pubitemid 32043092)
41. McCall MR, Frei B, (1999) Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Bio Med 26: 1034-1053. (Pubitemid 29198377)
42. Mehler-Wex C, Riederer P, Gerlach M, (2006) Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 10: 167-179.
43. Migliore L, Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Scarpato R, et al, (2002) Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology 58: 1809-1815. (Pubitemid 34663582)
44. Miyazaki I, Asanuma M, (2008) Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama 62: 141-150.
45. Moron JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM, et al, (2003) Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23: 8480-8488. (Pubitemid 37158747)
46. Murgia E, Ballardin M, Bonassi S, Rossi AM, Barale R, (2008) Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat Res-Fundam Mol Mech Mutagen 639: 27-34.
47. Oli RG, Fazeli G, Kuhn W, Walitza S, Gerlach M, Stopper H, (2010) No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot study. J Neural Transm 117: 737-746.
48. Petrozzi L, Lucetti C, Scarpato R, Gambaccini G, Trippi F, Bernardini S, et al, (2002) Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients. Neurol Sci 23 (Suppl. 2): S97-S98. (Pubitemid 35355794)
49. Pick E, Mizel D, (1981) Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 46: 211-226. (Pubitemid 11020859)
50. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD, (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17: 45-57. (Pubitemid 27008849)
51. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
52. Stopper H, Schupp N, Fazeli G, Dietel B, Queisser N, Walitza S, Gerlach M, (2009) Genotoxicity of the neurotransmitter dopamine in vitro. Toxicol In Vitro 23: 640-646.
53. Vaudry D, Stork PJ, Lazarovici P, Eiden LE, (2002) Signaling pathways for PC12 cell differentiation: making the right connections. Science 296: 1648-1649. (Pubitemid 34579153)
54. Waheed F, Speight P, Kawai G, Dan Q, Kapus A, Szaszi K, (2010) Extracellular signal regulated kinase and GEF-H1 mediate depolarization-induced Rho activation and paracellular permeability increase. Am J Physiol Cell Physiol 298: C1376-C1387.
55. Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, et al, (2007) Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem 282: 35842-35854. (Pubitemid 350277154)